ArticleTranslational vision science & technology2026
Benchmarking GPT-5, LLaMA, and Mistral for Clinical Named Entity Recognition in Ophthalmology Progress Notes.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To compare the performance of GPT-5, LLaMA 3.1-70B, and Mistral 7B in extracting clinically relevant entities from unstructured ophthalmology progress notes. Methods: We evaluated GPT-5, quantized and full-precision LLaMA 3.1-70B, and Mistral 7B on a corpus of 480 publicly available deidentified progress notes from patients with glaucoma at a single academic center. Each note was presented to all models using a standardized prompt. The outputs were manually annotated for six clinical entity types: ocular surgical history, follow-up dates, intraocular pressure (IOP), diagnostic tests and results, ocular conditions, and family history. Precision, recall, F1 score, and accuracy were calculated for each model. Micro- and macro-averaged evaluations were also performed, alongside stratification by note length and qualitative error analysis. Results: GPT-5 outperformed LLaMA 3.1-70B and Mistral 7B across all metrics, with its highest F1 score in surgical history extraction (0.929) and lowest in diagnostic tests (0.820). Full-precision LLaMA 3.1-70B and Mistral performed best on IOP extraction (F1 score: 0.875 and 0.884, respectively) and worst on diagnostic tests (F1 score: 0.338 and 0.642, respectively). Micro- and macro-averaged evaluations confirmed GPT-5's superior performance (F1: 0.941 micro, 0.936 macro) compared to full-precision LLaMA's (F1: 0.718 micro, 0.694 macro) and Mistral's (F1: 0.804 micro, 0.789 macro). Conclusions: These findings highlight the promise of large language models for accurate clinical information extraction from unstructured ophthalmic text. Translational Relevance: Large language models may offer the potential to streamline information retrieval, enhance clinical decision-making, and generate structured datasets that can accelerate research and improve patient outcomes in ophthalmology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.